Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report

Agnandji, Selidji T; Csaki Huttner, Angela; Zinser, Madeleine E; Njuguna, Patricia; Dahlke, Christine; Fernandes, José F; Yerly, Sabine; Dayer, Julie-Anne; Kraehling, Verena; Kasonta, Rahel; Adegnika, Akim A; Altfeld, Marcus; Auderset, Floriane; Bache, Emmanuel B; Biedenkopf, Nadine; Borregaard, Saskia; Brosnahan, Jessica S; Burrow, Rebekah; Combescure, Christophe; Desmeules, Jules Alexandre; Eickmann, Markus; Fehling, Sarah K; Finckh, Axel; Goncalves Cabecinhas, Ana Rita; Grobusch, Martin P; Hooper, Jay; Jambrecina, Alen; Kabwende, Anita L; Kaya, Gurkan; Kimani, Domtila; Lell, Bertrand; Lemaître, Barbara; Lohse, Ansgar W; Massinga-Loembe, Marguerite; Matthey, Alain; Mordmüller, Benjamin; Nolting, Anne; Ogwang, Caroline; Ramharter, Michael; Schmidt-Chanasit, Jonas; Schmiedel, Stefan; Silvera, Peter; Stahl, Felix R; Staines, Henry M; Strecker, Thomas; Stubbe, Hans C; Tsofa, Benjamin; Zaki, Sherif; Fast, Patricia; Moorthy, Vasee; Kaiser, Laurent; Krishna, Sanjeev; Becker, Stephan; Kieny, Marie-Paule; Bejon, Philip; Kremsner, Peter G; Addo, Marylyn M; Siegrist, Claire-Anne; VSV Ebola Consortium (VEBCON)

doi:10.1056/NEJMoa1502924

Article scientifique

Accès libre

Anglais

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report

Contributeurs/tricesAgnandji, Selidji T; Csaki Huttner, Angela; Zinser, Madeleine E; Njuguna, Patricia; Dahlke, Christine; Fernandes, José F; Yerly, Sabine; Dayer, Julie-Anne; Kraehling, Verena; Kasonta, Rahel; Adegnika, Akim A; Altfeld, Marcus; Auderset, Floriane; Bache, Emmanuel B; Biedenkopf, Nadine; Borregaard, Saskia; Brosnahan, Jessica S; Burrow, Rebekah; Combescure, Christophe

; Desmeules, Jules Alexandre; Eickmann, Markus; Fehling, Sarah K; Finckh, Axel; Goncalves Cabecinhas, Ana Rita; Grobusch, Martin P; Hooper, Jay; Jambrecina, Alen; Kabwende, Anita L; Kaya, Gurkan; Kimani, Domtila; Lell, Bertrand; Lemaître, Barbara; Lohse, Ansgar W; Massinga-Loembe, Marguerite; Matthey, Alain; Mordmüller, Benjamin; Nolting, Anne; Ogwang, Caroline; Ramharter, Michael; Schmidt-Chanasit, Jonas; Schmiedel, Stefan; Silvera, Peter; Stahl, Felix R; Staines, Henry M; Strecker, Thomas; Stubbe, Hans C; Tsofa, Benjamin; Zaki, Sherif; Fast, Patricia; Moorthy, Vasee; Kaiser, Laurent; Krishna, Sanjeev; Becker, Stephan; Kieny, Marie-Paule; Bejon, Philip; Kremsner, Peter G; Addo, Marylyn M; Siegrist, Claire-Anne; VSV Ebola Consortium (VEBCON)

Publié dansThe New England journal of medicine, vol. 374, no. 17, p. 1647-1660

Date de publication2016

Résumé

The replication-competent recombinant vesicular stomatitis virus (rVSV)–based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety and immunogenicity testing before its use in West Africa.

Structure d'affiliation

Faculté de médecine / Section de médecine clinique / Département de médecine

Groupe de recherche

Citation (format ISO)

AGNANDJI, Selidji T et al. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report. In: The New England journal of medicine, 2016, vol. 374, n° 17, p. 1647–1660. doi: 10.1056/NEJMoa1502924

Article (Published version)

Identifiants

PID : unige:74558
DOI : 10.1056/NEJMoa1502924
PMID : 25830326

ISSN du journal0028-4793

764vues

222téléchargements

Création20/07/2015 11:15:00

Première validation20/07/2015 11:15:00

Heure de mise à jour14/03/2023 23:32:09

Changement de statut14/03/2023 23:32:07

Dernière indexation16/01/2024 18:42:01

Archive ouverte UNIGE

Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary Report

The replication-competent recombinant vesicular stomatitis virus (rVSV)–based vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety and immunogenicity testing before its use in West Africa.

Informations techniques